Introduction
In a minority of patients with walled-off pancreatic necrosis (covered on the EUS-Cystogastrostomy page), simple drainage of the fluid isn't enough, because there's also dead tissue that needs to be physically removed. Endoscopic necrosectomy does exactly that — using the drainage tract already created between the stomach and the necrotic collection, an endoscope is passed through to directly remove the dead tissue, piece by piece, from inside the body. This represents a major shift from the historical standard, open surgical necrosectomy, which carried substantially higher complication and mortality rates.
Is this procedure safe, and does it work?
This deserves an honest, direct answer rather than only reassuring numbers, because the condition it treats — severe necrotizing pancreatitis — is genuinely serious on its own. In one of the largest published series (over 500 patients), clinical success with direct endoscopic necrosectomy was achieved in about 9 out of 10 patients, with long-term success maintained in a similar proportion. Complications occurred in roughly 1 in 10 patients, most commonly bleeding. It's important to understand that even with successful treatment, this illness carries a real mortality risk — reported at just under 6% in that same large series — reflecting how sick patients with this condition can be, not a failure of the procedure itself. What matters most for context: this endoscopic approach has substantially better outcomes than the older open surgical alternative, which historically carried much higher complication and death rates. The section further down this page, ‘The evidence in more detail,’ has the specific study data.
The step-up approach
Modern treatment of walled-off pancreatic necrosis follows a staged, 'step-up' approach: starting with the least invasive effective option and escalating only if needed. This typically means drainage first (see the EUS-Cystogastrostomy page), with direct necrosectomy added specifically for patients whose collection doesn't adequately resolve with drainage alone. Some research suggests that allowing more time between initial drainage and necrosectomy, when clinically appropriate, may reduce the need for further intervention afterward — timing is considered carefully, not rushed.
What to expect: before, during, and after
- Before: typically follows drainage (EUS-cystogastrostomy) that hasn't fully resolved the collection; imaging to assess the extent of remaining necrosis
- During: performed under general anesthesia; using the existing drainage tract, the endoscope removes dead tissue directly, often requiring multiple sessions rather than a single procedure
- After: close monitoring in hospital, with antibiotics continued as needed; recovery is gradual and tied to how much necrosis needed to be cleared
- Follow-up: repeat imaging to confirm resolution before further sessions are planned or treatment is considered complete
The evidence in more detail
This section is for anyone who wants the specific research behind the summary above — it's not necessary reading to understand the basics of this procedure, but it's here for transparency.
A large single-center study of 226 patients undergoing direct endoscopic necrosectomy during transmural drainage found clinical success in 89.82% and long-term success in 87.17%, with complications in 10.61% (most commonly gastrointestinal bleeding) and mortality of 5.75%. A study comparing timing of necrosectomy found that postponing the procedure, when clinically appropriate, was associated with a lower rate of needing additional intervention. Research on the staged, step-up approach found clinical success in over 90% of patients within roughly 11–12 days when managed with an endoscopic-first strategy. Historically, open surgical necrosectomy carried substantially higher complication and mortality rates, which is the key context for understanding why the endoscopic approach represents genuine progress in managing this serious condition.
Necrosectomy care at KAGE
Endoscopic necrosectomy follows on from EUS-guided cystogastrostomy: the stent creates the route into the collection, and the necrosectomy sessions clear the solid dead tissue through it. Our gastroenterologists stage this across several sessions rather than forcing it into one, which is much of why it is safer than open surgical debridement. For a referral or a second opinion on a walled-off collection, book a consultation.
Frequently asked questions
Yes, substantially — the endoscopic approach has significantly better outcomes than the older open surgical alternative, which is why it's now the preferred first approach in most cases.
Because honesty matters more than reassurance alone — severe necrotizing pancreatitis is a genuinely serious illness, and the risk reflects how unwell patients with this condition can be, not a shortcoming of the procedure itself, which performs far better than the historical surgical alternative.
Often more than one — necrosectomy is frequently done in stages across multiple sessions, based on how much tissue needs to be cleared and how the patient responds.
Coverage varies by policy; our team can help verify your specific coverage and explain costs during consultation.
This varies significantly based on the extent of necrosis and overall clinical picture — your care team can give a more specific estimate based on your situation.
Drainage removes fluid from a collection; necrosectomy goes a step further to physically remove solid dead tissue, and is added specifically when drainage alone doesn't fully resolve the problem.
In a small proportion of cases, additional intervention or a different approach is needed — your care team monitors progress closely with imaging throughout treatment to catch this early if it occurs.
Some evidence suggests allowing appropriate time for the collection to organize before necrosectomy may reduce the need for further intervention, so timing is a deliberate clinical decision, not simply done as soon as possible.
It's uncommon in children but can occur after severe pancreatitis; any pediatric case would be managed by KAGE's pediatric gastroenterology team.
Book a consultation at KAGE
Speak to a KAGE gastroenterologist about your symptoms, your diagnosis, or a second opinion.